Meet the Experts™

In the last 26 years, EGPAF has contributed to the most significant breakthroughs related to HIV in children, including discoveries that have helped to dramatically reduce the rate of mother-to-child transmission of HIV around the world (see timeline). EGPAF has expanded the research knowledge base around pediatric HIV, contributing to major advances regarding how HIV enters cells and the effects of early combination therapy in children. Active support for underfunded areas of innovative basic science research relevant to prevention, treatment, and cure of HIV in children remains a hallmark of EGPAF research priorities. Today, EGPAF plays a critical role in both defining the pediatric AIDS research agenda and supporting and conducting research to improve the lives of women, children, and families affected by HIV. EGPAF leads studies in clinical, laboratory, and implementation science research with a focus on optimizing health service delivery, building an evidence base for new and innovative interventions, and effectively scaling up promising HIV and maternal, newborn, and child health (MNCH) interventions. In addition to an extensive network of field sites in Africa, EGPAF has a Global Research Unit with clinical, community, regulatory, statistical, and qualitative and quantitative research expertise that facilitates, initiates, and supports on-the-ground research and evaluation across EGPAF-supported countries. EGPAF provides external funding support through two key award programs: the International Leadership Awards and the Susie Zeegen Postdoctoral Fellowship Award.